November 4th, 2019
Peter Attia has a vary important podcast for you to listen to: #71episode,
Katherine Eban, investigative journalist and author of Bottle of Lies, illuminates the prevalence of fraud in generic drug manufacturing which brings into question the idea that generics are identical to brand-name drug as we are lead to believe. Katherine walks us through how this widespread corruption came to be, including the shocking story of one particularly egregious (and unfortunately not uncommon) example of an Indian drug company, Ranbaxy, whose business model was completely dependent on falsifying data in their drug applications to the FDA.
We then discuss the subsequent investigation into Indian and Chinese drug manufacturing plants which revealed that nearly 80% of them are tainted with fraud. We conclude this discussion on a positive note with i) how individuals can investigate their own drugs to protect themselves ii) an innovative pharmacy attempting to disrupt the market and iii) some ideas on how to reform to the regulations around generic drugs, the FDA, and more." Peter Attia
If you ever wondered why the generic drug that your insurance company forced you to switch to did not work, despite you paying insane premiums for said insurance, Dr. Attia answers this question. It is a very sad reality that we, the consumers of healthcare, have to constantly be on high alert for deceptive practices like the falsified generic drug market of India and China. If you or a family member is reliant on a drug for survival or health, I HIGHLY HIGHLY encourage you to listen to this podcast.